Exclusive: Time to Buy Rockwell Medical Inc After Today’s Big Increase?

Exclusive: Time to Buy Rockwell Medical Inc After Today's Big Increase?

The stock of Rockwell Medical Inc (NASDAQ:RMTI) is a huge mover today! About 372,866 shares traded hands. Rockwell Medical Inc (NASDAQ:RMTI) has declined 33.29% since April 8, 2016 and is downtrending. It has underperformed by 38.94% the S&P500.
The move comes after 8 months positive chart setup for the $292.27 million company. It was reported on Nov, 10 by Barchart.com. We have $15.58 PT which if reached, will make NASDAQ:RMTI worth $581.62 million more.

Analysts await Rockwell Medical Inc (NASDAQ:RMTI) to report earnings on November, 14. They expect $-0.10 EPS, down 100.00% or $0.05 from last year’s $-0.05 per share. After $-0.11 actual EPS reported by Rockwell Medical Inc for the previous quarter, Wall Street now forecasts -9.09% EPS growth.

Rockwell Medical Inc (NASDAQ:RMTI) Ratings Coverage

Out of 2 analysts covering Rockwell Medical (NASDAQ:RMTI), 0 rate it a “Buy”, 2 “Sell”, while 0 “Hold”. This means 0 are positive. Rockwell Medical has been the topic of 5 analyst reports since August 6, 2015 according to StockzIntelligence Inc. The stock of Rockwell Medical Inc (NASDAQ:RMTI) has “Sell” rating given on Thursday, August 13 by TheStreet. Bank of America downgraded the shares of RMTI in a report on Tuesday, November 8 to “Underperform” rating. The firm has “Outperform” rating given on Thursday, August 6 by Oppenheimer. The company was maintained on Saturday, August 22 by Oppenheimer. Morgan Stanley initiated Rockwell Medical Inc (NASDAQ:RMTI) rating on Thursday, August 13. Morgan Stanley has “Underweight” rating and $7 price target.

According to Zacks Investment Research, “Rockwell Medical Technologies, Inc. manufactures hemodialysis concentrates and dialysis kits, and sells, distributes and delivers such concentrates and dialysis kits, as well as other ancillary hemodialysis products, to hemodialysis providers in the United States. Hemodialysis is a process which is able to duplicate kidney function in patients whose kidneys have failed to function properly.”

Insitutional Activity: The institutional sentiment decreased to 0.9 in Q2 2016. Its down 0.26, from 1.16 in 2016Q1. The ratio turned negative, as 11 funds sold all Rockwell Medical Inc shares owned while 28 reduced positions. 9 funds bought stakes while 26 increased positions. They now own 10.76 million shares or 10.05% less from 11.96 million shares in 2016Q1.
California State Teachers Retirement Sys holds 100,477 shares or 0% of its portfolio. Granahan Invest Management Ma holds 222,852 shares or 0.06% of its portfolio. Retail Bank Of Montreal Can holds 0% or 144,523 shares in its portfolio. Jpmorgan Chase & holds 0% or 31,369 shares in its portfolio. Zurcher Kantonalbank (Zurich Cantonalbank) has 1,547 shares for 0% of their US portfolio. Blackrock Grp Ltd reported 27,970 shares or 0% of all its holdings. The New York-based Morgan Stanley has invested 0% in Rockwell Medical Inc (NASDAQ:RMTI). Parametric Portfolio Associates Lc accumulated 0% or 12,751 shares. Ubs Asset Management Americas Inc last reported 0% of its portfolio in the stock. Blackrock Invest Mngmt Ltd Liability Corporation accumulated 0% or 192,817 shares. Alliancebernstein L P has 73,600 shares for 0% of their US portfolio. Great West Life Assurance Comm Can last reported 4,883 shares in the company. State Board Of Administration Of Florida Retirement System accumulated 0% or 26,889 shares. Tiaa Cref Investment Mngmt Llc reported 144,518 shares or 0% of all its holdings. Huntington Bank & Trust has invested 0% of its portfolio in Rockwell Medical Inc (NASDAQ:RMTI).

Insider Transactions: Since August 12, 2016, the stock had 0 insider purchases, and 4 selling transactions for $105,555 net activity. HOLT KENNETH L also sold $26,991 worth of Rockwell Medical Inc (NASDAQ:RMTI) shares.

More notable recent Rockwell Medical Inc (NASDAQ:RMTI) news were published by: Fool.com which released: “3 Ways Rockwell Medical Inc. Could Turn Things Around” on October 07, 2016, also Fool.com with their article: “3 Predictions for Rockwell Medical Inc. in 2016” published on December 10, 2015, Fool.com published: “Will Rockwell Medical Inc. Sink or Swim?” on April 06, 2016. More interesting news about Rockwell Medical Inc (NASDAQ:RMTI) were released by: Fool.com and their article: “Why Rockwell Medical, Inc. Shares Are Crashing Today” published on March 01, 2016 as well as Fool.com‘s news article titled: “Rockwell Medical Stock Upgraded: What You Need to Know” with publication date: August 19, 2016.

RMTI Company Profile

Rockwell Medical, Inc. (Rockwell), incorporated on October 25, 1996, is a biopharmaceutical firm targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with services and products for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The Firm operates through the hemodialysis market segment, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceutical, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. The Company’s lead branded drug, Triferic is indicated for iron maintenance.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Comment